Powered by

Stemline Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Jan 02, 2019 - GlobeNewswire
Event Announcements

NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 5:00 PM PT at the Westin St. Francis Hotel in San Francisco, CA. A live webcast of the presentation can be viewed on the company's website at ww...